• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低氧处理对磷酸甘油酸激酶表达以及曲沙他滨和吉西他滨细胞毒性的影响。

The impact of hypoxic treatment on the expression of phosphoglycerate kinase and the cytotoxicity of troxacitabine and gemcitabine.

作者信息

Lam Wing, Leung Chung-Hang, Bussom Scott, Cheng Yung-Chi

机构信息

Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.

出版信息

Mol Pharmacol. 2007 Sep;72(3):536-44. doi: 10.1124/mol.106.033472. Epub 2007 Jun 12.

DOI:10.1124/mol.106.033472
PMID:17565005
Abstract

beta-L-Dioxolane-cytidine (L-OddC, Troxacitabine, BCH-4556), a novel L-configuration deoxycytidine analog, is under clinical trials for treating cancer. The cytotoxicity of L-OddC is dependent on the amount of the triphosphate form (L-OddCTP) in nuclear DNA. Phosphoglycerate kinase (PGK), a downstream protein of hypoxia-inducible-factor-1alpha (HIF-1alpha), is responsible for the phosphorylation of the diphosphate to the triphosphate of L-OddC. In this study, we studied the impact of hypoxia on the metabolism and the cytotoxicity of L-OddC and beta-d-2',2'-difluorodeoxycytidine (dFdC) in several human tumor cell lines including HepG2, Hep3B, A673, Panc-1, and RKO. Hypoxic treatment induced the protein expression of PGK 3-fold but had no effect on the protein expression of APE-1, dCK, CMPK, and nM23 H1. Hypoxic treatment increased L-OddCTP formation and incorporation of L-OddC into DNA, but it decreased the uptake and incorporation of dFdC, which correlated with the reduction of hENT1, hENT2, and hCNT2 expression. Using a clonogenic assay, hypoxic treatment of cells made them 2- to 3-fold more susceptible to L-OddC but not to dFdC after exposure to drugs for one generation. Dimethyloxallyl glycine enhanced the cytotoxicity of L-OddC but not dFdC in Panc-1 cells under normoxic conditions. Overexpression or down-regulation of PGK using transient transfection of pcDNA5-PGK or inducible shRNA in RKO cells affected the cytotoxicity of L-OddC but not that of dFdC. The knockdown of HIF-1alpha in inducible shRNA in RKO cells reduced the cytotoxicity of L-OddC but not dFdC under hypoxic conditions. In conclusion, hypoxia is an important factor that may potentiate the activity of L-OddC.

摘要

β-L-二氧戊环胞苷(L-OddC,曲沙他滨,BCH-4556)是一种新型的L构型脱氧胞苷类似物,正在进行治疗癌症的临床试验。L-OddC的细胞毒性取决于核DNA中三磷酸形式(L-OddCTP)的含量。磷酸甘油酸激酶(PGK)是缺氧诱导因子-1α(HIF-1α)的下游蛋白,负责将L-OddC的二磷酸磷酸化为三磷酸。在本研究中,我们研究了缺氧对几种人类肿瘤细胞系(包括HepG2、Hep3B、A673、Panc-1和RKO)中L-OddC和β-d-2',2'-二氟脱氧胞苷(dFdC)代谢及细胞毒性的影响。缺氧处理使PGK蛋白表达增加3倍,但对APE-1、dCK、CMPK和nM23 H1的蛋白表达没有影响。缺氧处理增加了L-OddCTP的形成以及L-OddC掺入DNA,但降低了dFdC的摄取和掺入,这与hENT1、hENT2和hCNT2表达的降低相关。使用克隆形成试验,在细胞暴露于药物一代后,缺氧处理使它们对L-OddC的敏感性提高2至3倍,但对dFdC不敏感。在常氧条件下,二甲基草酰甘氨酸增强了Panc-1细胞中L-OddC的细胞毒性,但对dFdC没有影响。在RKO细胞中使用pcDNA5-PGK瞬时转染或诱导性shRNA过表达或下调PGK影响了L-OddC的细胞毒性,但对dFdC没有影响。在RKO细胞中使用诱导性shRNA敲低HIF-1α降低了缺氧条件下L-OddC的细胞毒性,但对dFdC没有影响。总之,缺氧是可能增强L-OddC活性的一个重要因素。

相似文献

1
The impact of hypoxic treatment on the expression of phosphoglycerate kinase and the cytotoxicity of troxacitabine and gemcitabine.低氧处理对磷酸甘油酸激酶表达以及曲沙他滨和吉西他滨细胞毒性的影响。
Mol Pharmacol. 2007 Sep;72(3):536-44. doi: 10.1124/mol.106.033472. Epub 2007 Jun 12.
2
Effect of hypoxia on the expression of phosphoglycerate kinase and antitumor activity of troxacitabine and gemcitabine in non-small cell lung carcinoma.缺氧对非小细胞肺癌中磷酸甘油酸激酶表达以及曲西他滨和吉西他滨抗肿瘤活性的影响
Mol Cancer Ther. 2009 Feb;8(2):415-23. doi: 10.1158/1535-7163.MCT-08-0692. Epub 2009 Feb 10.
3
Apurinic/apyrimidinic endonuclease-1 protein level is associated with the cytotoxicity of L-configuration deoxycytidine analogs (troxacitabine and beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine) but not D-configuration deoxycytidine analogs (gemcitabine and beta-D-arabinofuranosylcytosine).脱嘌呤/脱嘧啶内切酶-1蛋白水平与L构型脱氧胞苷类似物(曲西他滨和β-L-2',3'-二脱氧-2',3'-二脱氢-5-氟胞苷)的细胞毒性相关,但与D构型脱氧胞苷类似物(吉西他滨和β-D-阿拉伯呋喃糖基胞嘧啶)无关。
Mol Pharmacol. 2006 May;69(5):1607-14. doi: 10.1124/mol.105.021527. Epub 2006 Feb 15.
4
A novel action of human apurinic/apyrimidinic endonuclease: excision of L-configuration deoxyribonucleoside analogs from the 3' termini of DNA.人脱嘌呤/脱嘧啶内切核酸酶的一种新作用:从DNA的3'末端切除L构型脱氧核糖核苷类似物。
J Biol Chem. 2000 Oct 6;275(40):31009-15. doi: 10.1074/jbc.M004082200.
5
Synergistic antitumor activity of troxacitabine and camptothecin in selected human cancer cell lines.曲沙他滨与喜树碱在特定人类癌细胞系中的协同抗肿瘤活性。
Mol Pharmacol. 2004 Aug;66(2):285-92. doi: 10.1124/mol.66.2.285.
6
Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines.新型脱氧胞苷核苷类似物曲扎西他滨在人白血病和实体瘤细胞系中的摄取及耐药机制
Cancer Res. 2001 Oct 1;61(19):7217-24.
7
UMP/CMPK is not the critical enzyme in the metabolism of pyrimidine ribonucleotide and activation of deoxycytidine analogs in human RKO cells.UMP/CMPK 不是嘧啶核苷酸代谢和人 RKO 细胞中脱氧胞苷类似物激活的关键酶。
PLoS One. 2011 May 3;6(5):e19490. doi: 10.1371/journal.pone.0019490.
8
Synergistic activity of troxacitabine (Troxatyl) and gemcitabine in pancreatic cancer.曲沙他滨(Troxatyl)与吉西他滨在胰腺癌中的协同活性。
BMC Cancer. 2007 Jul 3;7:121. doi: 10.1186/1471-2407-7-121.
9
Cyclopentenyl cytosine-induced activation of deoxycytidine kinase increases gemcitabine anabolism and cytotoxicity in neuroblastoma.环戊烯基胞嘧啶诱导的脱氧胞苷激酶激活增加了吉西他滨在神经母细胞瘤中的合成代谢及细胞毒性。
Cancer Chemother Pharmacol. 2006 Jan;57(1):105-13. doi: 10.1007/s00280-005-0005-8. Epub 2005 Nov 5.
10
Regulation of phosphorylation of deoxycytidine and 2',2'-difluorodeoxycytidine (gemcitabine); effects of cytidine 5'-triphosphate and uridine 5'-triphosphate in relation to chemosensitivity for 2',2'-difluorodeoxycytidine.脱氧胞苷和2',2'-二氟脱氧胞苷(吉西他滨)磷酸化的调节;5'-三磷酸胞苷和5'-三磷酸尿苷与2',2'-二氟脱氧胞苷化学敏感性的关系
Biochem Pharmacol. 1996 Apr 12;51(7):911-8. doi: 10.1016/0006-2952(95)02402-6.

引用本文的文献

1
Aptamer nucleotide analog drug conjugates in the targeting therapy of cancers.适体核苷酸类似物药物偶联物在癌症靶向治疗中的应用
Front Cell Dev Biol. 2022 Dec 5;10:1053984. doi: 10.3389/fcell.2022.1053984. eCollection 2022.
2
Glycometabolic rearrangements--aerobic glycolysis in pancreatic cancer: causes, characteristics and clinical applications.糖代谢重排——胰腺癌中的有氧糖酵解:原因、特征和临床应用。
J Exp Clin Cancer Res. 2020 Nov 30;39(1):267. doi: 10.1186/s13046-020-01765-x.
3
Using gene expression data to identify certain gastro-intestinal diseases.
利用基因表达数据识别某些胃肠道疾病。
J Clin Bioinforma. 2012 Nov 21;2(1):20. doi: 10.1186/2043-9113-2-20.
4
Attenuation of phosphorylation by deoxycytidine kinase is key to acquired gemcitabine resistance in a pancreatic cancer cell line: targeted proteomic and metabolomic analyses in PK9 cells.脱氧胞苷激酶磷酸化的衰减是胰腺癌细胞系获得吉西他滨耐药的关键:PK9 细胞中的靶向蛋白质组学和代谢组学分析。
Pharm Res. 2012 Jul;29(7):2006-16. doi: 10.1007/s11095-012-0728-2. Epub 2012 Mar 15.
5
Transplanting normal vascular proangiogenic cells to tumor-bearing mice triggers vascular remodeling and reduces hypoxia in tumors.将正常的血管生成细胞移植到荷瘤小鼠中可触发血管重塑并减少肿瘤中的缺氧。
Cancer Res. 2010 Aug 1;70(15):6283-92. doi: 10.1158/0008-5472.CAN-10-0412. Epub 2010 Jul 14.
6
Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.更新药物代谢系统信息——2009 年,第二部分:疾病和环境因素对人细胞色素 P450(CYP)酶和转运体影响的信息摘要。
Curr Drug Metab. 2010 Jan;11(1):4-84. doi: 10.2174/138920010791110917.